Adnexal Mass Clinical Trial
— CAMBRIDGEOfficial title:
Accuracy of the Characterization of Adnexal Masses, Indeterminate at Ultrasonography, Using a Magnetic Resonance Imaging Protocol Without Contrast: Validation of the Cambridge Score
NCT number | NCT05815992 |
Other study ID # | 4298 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | September 1, 2021 |
Est. completion date | December 2024 |
Verified date | March 2023 |
Source | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of this prospective observational study is to evaluate the accuracy and to validate the Cambridge Score,a Test Index to predict the malignancy of the ovarian lesions on the basis of an MRI examination without contrast
Status | Recruiting |
Enrollment | 370 |
Est. completion date | December 2024 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age > 18 years; - Indeterminate adnexal masses at the ultrasonography; - Signed Informed Consent. Exclusion Criteria: - Diagnosis of an extraovary mass; - Synchronous tumors; - Previous history of neoplasy. |
Country | Name | City | State |
---|---|---|---|
Italy | Fondazione Policlinico Universitaro "A. Gemelli" IRCCS | Roma |
Lead Sponsor | Collaborator |
---|---|
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of generalizability of the Cambridge Score through external validations | Through study completion, an average of 3 years | ||
Secondary | Evaluation of Cambridge Score when diagnosed by different readers | Through study completion, an average of 3 years | ||
Secondary | Evaluation of diagnostic agreement between the Non-contrast and contrast-enhanced MRI | Through study completion, an average of 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06366997 -
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
|
||
Completed |
NCT00987649 -
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
|
N/A | |
Completed |
NCT04260334 -
Preoperative Care In Ovarian Cancer Patients
|
N/A | |
Terminated |
NCT04668521 -
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
|
||
Recruiting |
NCT05842629 -
Improved Diagnosis of Ovarian Cancer
|
||
Recruiting |
NCT05974618 -
Prospective Validation of the ADNEX Model for Discrimination Between Benign and Malignant Adnexal Masses in Pregnancy: International Ovarian Tumour Analysis in Pregnancy Study (p-IOTA)
|
||
Terminated |
NCT04487405 -
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants
|
||
Recruiting |
NCT05017246 -
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
|
Phase 2 | |
Not yet recruiting |
NCT05761275 -
Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach
|
N/A | |
Not yet recruiting |
NCT03442881 -
The Use of International Ovarian Tumor Analysis and Assessment of Adnexal Neoplasia in Differentiating Malignant and Benign Adnexal Masses
|
N/A | |
Completed |
NCT01466049 -
New Biomarkers Evaluating Ovarian Cancer
|
N/A | |
Terminated |
NCT03485651 -
Natera Ovarian Cancer Detection Assay
|
||
Active, not recruiting |
NCT04051502 -
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
|
||
Recruiting |
NCT05051722 -
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
|
||
Completed |
NCT03593681 -
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
|
||
Completed |
NCT02520115 -
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
|
Phase 1 | |
Recruiting |
NCT05461872 -
Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES
|
||
Completed |
NCT03297112 -
Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery
|
Early Phase 1 | |
Completed |
NCT03837327 -
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy
|